Literature DB >> 7750935

Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.

B M Ronnett1, R J Kurman, C M Zahn, B M Shmookler, K A Jablonski, M E Kass, P H Sugarbaker.   

Abstract

Pseudomyxoma peritonei (PMP) is a poorly understood condition characterized by the accumulation of abundant mucinous material within the peritoneal cavity and associated with a mucinous tumor of the gastrointestinal tract or ovaries. Recently there has been considerable debate over the primary site of origin of the tumor associated with PMP in women. Some investigators have proposed a primary site in the ovaries, whereas others favor the gastrointestinal tract or the peritoneum. Another confusing issue has been the nature of the ovarian mucinous tumors associated with PMP. Although these neoplasms may be frankly malignant, more often they show minimal cytologic atypia and epithelial proliferation and have been classified as borderline or low malignant potential tumors. In order to address the issues of site of origin and nature of the associated ovarian mucinous tumors, we studied 68 cases of PMP in women, 30 of whom had mucinous tumors involving the ovaries. All 30 of these cases had an associated mucinous appendiceal or intestinal tumor. The PMP cases with ovarian tumors were compared with 30 ovarian mucinous tumors of low malignant potential (LMP). Based on the analysis of the primary ovarian mucinous LMP tumors, a set of criteria was formulated and used to determine the probable site of origin of PMP in the 30 women with mucinous tumors involving the ovaries. The following gross and microscopic features of the ovarian tumor were considered to be inconsistent with a primary ovarian origin: (1) surface involvement with or without superficial stromal involvement only; (2) adenocarcinoma with signet ring cell differentiation, with a previously diagnosed or concurrent appendiceal tumor of similar morphology; (3) bilateral adenocarcinoma consistent with colonic or appendiceal morphology; and (4) unilateral adenocarcinoma consistent with colonic or appendiceal morphology with a history of a colonic or appendiceal adenocarcinoma. When any one of these features was present the ovarian tumor was diagnosed as secondary. The following additional features also were considered to be more typical of secondary ovarian involvement: (1) normal or only slightly enlarged ovaries; (2) bilateral ovarian involvement; (3) simple or only focally proliferative mucinous epithelium with abundant extracellular mucin in cases with predominantly surface involvement of the ovaries, with or without a history of/or concurrent appendiceal adenoma; (4) multifocal or extensive pseudomyxoma ovarii in cases with stromal involvement, with or without a history of/or concurrent appendiceal adenoma; (5) ruptured appendiceal adenoma and unruptured ovarian tumor of similar histology; and (6) presence of an associated mucinous intestinal tumor.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7750935     DOI: 10.1016/0046-8177(95)90247-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

Review 1.  Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation.

Authors:  Nam Kyung Lee; Suk Kim; Hyun Sung Kim; Tae Yong Jeon; Gwang Ha Kim; Dong Uk Kim; Do Youn Park; Tae Un Kim; Dae Hwan Kang
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Scalloping of liver in a patient with ascites: pseudomyxoma peritonei.

Authors: 
Journal:  J Clin Exp Hepatol       Date:  2013-02-08

3.  Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.

Authors:  Álvaro Arjona-Sánchez; Francisco C Muñoz-Casares; Sebastián Rufián-Peña; Rafael Díaz-Nieto; Ángela Casado-Adam; María J Rubio-Pérez; Rosa Ortega-Salas
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

4.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

5.  Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Robert M Smeenk; Vic J Verwaal; Ninja Antonini; Frans A N Zoetmulder
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  Pseudomyxoma peritonei arising from intraductal papillary neoplasm after surgical pancreatectomy: report of 2 cases and review of the literature.

Authors:  Hiroshi Imaoka; Kenji Yamao; Susumu Hijioka; Kazuo Hara; Nobumasa Mizuno; Tsutomu Tanaka; Shinya Kondo; Masahiro Tajika; Yasuhiro Shimizu; Yasumasa Niwa
Journal:  Clin J Gastroenterol       Date:  2011-12-21

7.  Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  Alvaro Arjona-Sanchez; Francisco Cristobal Muñoz-Casares; Angela Casado-Adam; Juan Manuel Sánchez-Hidalgo; Maria Dolores Ayllon Teran; Rafael Orti-Rodriguez; Ana Cristina Padial-Aguado; Javier Medina-Fernández; Rosa Ortega-Salas; Gema Pulido-Cortijo; Auxiliadora Gómez-España; Sebastián Rufián-Peña
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

8.  "The Jelly Belly": Diagnostic Dilemmas and Current Concepts.

Authors:  Priyanka Punit Kedia; Gayatri Ravikumar; Suravi Mohanty; Julian Crasta; Elizabeth Vallikad
Journal:  J Obstet Gynaecol India       Date:  2016-07-01

9.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

Authors:  Chin-Fan Chen; Che-Jen Huang; Wan-Yi Kang; Jan-Sing Hsieh
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

10.  Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential - A Comparison of Two Cases.

Authors:  Ira Winer; Ronald J Buckanovich
Journal:  Case Rep Oncol       Date:  2009-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.